Published on 5 Nov 2021 on Zacks via Yahoo Finance
CryoLife (CRY) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.13 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 420%. A quarter ago, it was expected that this biological medical device maker would post a loss of $0.05 per share when it actually produced a loss of $0.06, delivering a surprise of -20%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.